| Literature DB >> 15673785 |
Merritt P Edlind1, W Lamar Smith, Thomas D Edlind.
Abstract
Mouthwash antiseptic cetylpyridinium chloride (CPC) has potent activity against Candida albicans; however, two of five azole-resistant strains showed reduced CPC susceptibility. To further examine the potential for cross-resistance, CPC-resistant mutants were selected in vitro and their fluconazole susceptibility was tested. MICs were unchanged, and trailing growth generally decreased. With CPC-fluconazole combinations, both antagonism and synergism were observed, which can be explained, in part, by CDR1-CDR2 multidrug transporter upregulation.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15673785 PMCID: PMC547338 DOI: 10.1128/AAC.49.2.843-845.2005
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191